Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Ursodeoxycholic Acid Market Grown from 2024 to 2025?

In recent times, the market size of ursodeoxycholic acid has seen a significant expansion. It’s expected to escalate from a value of $0.86 billion in 2024 to $0.96 billion in 2025, marking a compound annual growth rate (CAGR) of 11.1%. Factors such as the increasing occurrence of gallstone disease, a surge in consciousness about liver health, escalating diagnosis rates for primary biliary cholangitis, higher usage of non-invasive liver function tests, and the rise in the elderly population are key contributors to the growth observed in the historic period.

What Growth Rate Is Anticipated for the Ursodeoxycholic Acid Market in the Coming Years?

In the coming years, the market size of ursodeoxycholic acid is projected to undergo swift expansion. By 2029, it is anticipated to reach a valuation of $1.44 billion, growing at a compound annual growth rate (CAGR) of 10.8%. This growth within the forecast period can be credited to the increasing incidences of diseases related to lifestyle, burgeoning demand for drugs that protect the liver, growing need for therapies tackling chronic liver diseases, a rising pipeline of clinical trials for bile acid derivatives, and the escalating demand for minimally invasive surgeries. Key trends predicted for the forecast period comprise the development of targeted drug delivery systems, the integration of ursodeoxycholic acid with other compounds that protect the liver, drug formulation innovation, the creation of new bile acid analogs, and the development of RNA-based therapies for the regeneration of the liver.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24734&type=smp

Who Are the Leading Companies in the Ursodeoxycholic Acid Market?

Major companies operating in the ursodeoxycholic acid market are Mankind Pharma Pvt. Ltd, Abbott Healthcare Pvt. Ltd., Shandong Octagon Chemicals Limited, J.S.C. Grindeks, Arch Pharmalabs, Ind Swift Laboratories Ltd., Symbiotec Pharmalab, Suzhou Tianlu Bio-pharmaceutical Co. Ltd, Zeal MediPharma, Prodotti Chimici e Alimentari S.P.A., Mitsubishi Tanabe Pharma Corporation, ICE Pharma Inc, Xi’an Tian Guangyuan Biotech Co. Ltd, Aamorb Pharmaceuticals Inc., Axplora Inc, Octavius Pharma Pvt. Ltd, Sichuan Elixir Pharmaceutical Co. Ltd, Signova Pharma Pvt. Ltd., Sinoway Industrial Co. Ltd, Valence Labs Pvt. Ltd.

What Are the Key Drivers of the Ursodeoxycholic Acid Market?

The increasing incidence of liver conditions is anticipated to spur the expansion of the ursodeoxycholic acid market in the future. Liver conditions encompass a range of issues that obstruct the liver’s capability to function to its full potential, including infections, inflammation, fatty liver, cirrhosis, and liver cancer. The growing incidence of these liver conditions can be attributed to a rise in alcohol consumption, as chronic overconsumption can result in liver damage. Ursodeoxycholic acid plays a crucial role in the treatment of liver diseases by enhancing bile flow and lowering harmful bile acids, rendering it beneficial for conditions like primary biliary cholangitis. It improves patient results by retarding the advancement of liver damage and aiding in the dissolution of cholesterol gallstones, thereby boosting overall treatment effectiveness. For example, figures from the Office for Health Improvement and Disparities, a government department based in the UK, indicated that in April 2024, there were 6,664 premature deaths due to liver disease among males and 3,929 among females, reflecting a 22.8% rise for males and a 33.1% rise for females compared to prior years. As a result, the escalating incidence of liver diseases is fuelling the growth of the ursodeoxycholic acid market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24734&type=smp

What Are the Key Market Segments in the Ursodeoxycholic Acid Industry?

The ursodeoxycholic acid market covered in this report is segmented –

1) By Type: Synthetic Ursodeoxycholic Acid, Extraction Ursodeoxycholic Acid

2) By Route Of Administration: Oral, Intravenous, Subcutaneous

3) By Application: Gallstones, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Other Liver And Biliary Diseases

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End User: Hospitals, Specialty Clinics, Research Institutions, Other End Users

Subsegments:

1) By Synthetic Ursodeoxycholic Acid: Chemically Synthesized Ursodeoxycholic Acid, Biosynthetic Ursodeoxycholic Acid, Enzymatically Synthesized Ursodeoxycholic Acid

2) By Extraction Ursodeoxycholic Acid: Animal-Derived Ursodeoxycholic Acid, Bile Extracted Ursodeoxycholic Acid, Natural Source Extracted Ursodeoxycholic Acid

What Are the Latest Trends in the Ursodeoxycholic Acid Market?

Leading firms in the ursodeoxycholic acid (UDCA) market are concentrating their efforts on the creation of groundbreaking therapies like bile acid derivatives. These derivatives are largely designed to improve the management and treatment of liver diseases, especially cholestatic liver conditions. They are essentially modified versions of bile acids employed in medical remedies to bolster liver functions and control liver disorders. For example, in November 2024, Nora Pharma Inc., a pharmaceutical company headquartered in Canada, unveiled a generic form of Ursodiol (ursodeoxycholic acid) aimed at treating a range of cholestatic liver diseases such as primary biliary cholangitis (PBC). The drug is primarily prescribed to boost liver functions and stall the advancement of liver damage, particularly when administered in the early stages of the disease. It further helps in the dissolution and prevention of cholesterol gallstones by altering bile composition and reducing harmful bile acids.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ursodeoxycholic-acid-global-market-report

What Are the Key Regional Markets in the Ursodeoxycholic Acid Industry?

North America was the largest region in the ursodeoxycholic acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ursodeoxycholic acid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24734

This Report Delivers Insight On:

1. How big is the ursodeoxycholic acid market, and how is it changing globally?

2. Who are the major companies in the ursodeoxycholic acid market, and how are they performing?

3. What are the key opportunities and risks in the ursodeoxycholic acid market right now?

4. Which products or customer segments are growing the most in the ursodeoxycholic acid market?

5. What factors are helping or slowing down the growth of the ursodeoxycholic acid market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model